Pharmacokinetic Modeling of Disposition and Time-Course Studies With [ 14 C]Atrazine

References

• Stevens , J. T. , Breckenridge , C. B. and Wetzel , L. 1999 . A risk characterization for atrazine: Oncogenicity profile . J. Toxicol. Environ. Health , 56 : 69 – 109 .
   PubMed Web of Science ®Google Scholar
• Allison , A. C. 1960 . Turnovers of erythrocytes and plasma proteins in mammals . Nature (Lond.) , 188 : 37 – 40 .
   PubMed Web of Science ®Google Scholar
• Andersen , M. E. , Clewell , H. J. 3rd , Gargas , M. L. and Connolly , R. B. 1986 . A physiologic pharmacokinetic model for hepatic glutathione (GSH) depletion by inhaled halogenated hydrocarbons . Toxicologist , 6 : 148
   Google Scholar
• Bakke , J. , Robbins , J. and Feil , V. 1971 . Metabolism of 2-methoxy-4-ethylamini-6-sec-butylamino-s-triazine . J Arg. Food Chem. , 19 : 462 – 466 .
   PubMed Web of Science ®Google Scholar
• Brown , R. P. , Delp , M. D. , Lindstedt , S. L. , Rhomberg , L. R. and Beliles , R. P. 1997 . Physiological parameter valuses for physiologically based pharmacokinetic models . Toxicol. Ind. Health , 13 : 407 – 484 .
   PubMed Web of Science ®Google Scholar
• Christensen , J. H. , Andreasen , F. and Jensen , E. B. 1980 . The binding of thiopental to serum proteins determined by ultrafiltration and equilibrium dialysis . Acta Pharmacol. Toxicol. (Copenh.) , 47 : 24 – 32 .
   PubMedGoogle Scholar
• Cooper , R. L. , Stoker , T. E. , Goldman , J. M. and McElroy , W. K. 2000 . Atrazine dstrupts the hypothalamic control of pituitary-ovarian function . Toxicol. Sci. , 53 : 297 – 307 .
   PubMed Web of Science ®Google Scholar
• Crammer , B. K. , Brzezicki , J. M. , Tessari , J. D. and Andersen , M. E. 2002 . Quantitative identification of atrazine (ATRA) and diaminochlorotrizine (DACT) in rat whole blood utilizing GC/MS/SIM . Toxicologist , 66 : 65
   Google Scholar
• D'Souza , R. W. , Francis , W. R. and Andersen , M. E. 1988 . Physiological model for tissue glutathione depletion and increased resynthesis after ethylence dichloride exposure . J. Pharmacol. Exp. Ther. , 245 : 563 – 568 .
   PubMed Web of Science ®Google Scholar
• Eldrige , J. , Fleenor-Heysor , D. G. , Extrom , P. C. , Wetzel , L. T. , Breckenridge , C. B. , Gillis , J. H. , Luempert , L. G. III and Stevens , J. T. 1994 . Short-term effects of chlorotriazines on estrous in female Sprague-Dawley and Fischer 344 Rats . J. Toxicol. Environ. Health , 43 : 155 – 167 .
   PubMed Web of Science ®Google Scholar
• Eldridge , J. C. , Wetzel , L. T. , Stevens , J. T. and Simpkins , J. W. 1999 . The mammary tumor response in triazine-treated female rats: A threshold-mediated interaction with strain and species-specific reproductive senescence . Steroids , 64 : 672 – 678 .
   PubMed Web of Science ®Google Scholar
• Eldridge , J. C. , Wetzel , L. T. and Tyrey , L. F . 1999 . Estrous cycle patterns of Sprague-Dawley rats during acute and chronic atrazine administration . Reprod. Toxicol. , 13 : 491 – 499 .
   PubMed Web of Science ®Google Scholar
• Hamboeck , H. , Fischer , W. , Di lorio , E. E. and Winterhalter , K. H. 1981 . The bindings of s-triazine metabolites to rodent hemoglobin appears irrelevant to other speices . Mol. Pharmacol. , 20 : 579 – 584 .
   PubMed Web of Science ®Google Scholar
• ILSI . 2001 . Developing strategies for agricultural chemical safety evaluation , 1 – 52 . Washington, DC : ILSI Health and Environmental Sciences Institute .
   Google Scholar
• Reitz , R. H. , MCCroskey , P. S. , Park , C. N. , Andersen , M. E. and Gargas , M. L. 1990 . Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxane . Toxicol. Appl. Pharmacol. , 105 : 37 – 54 .
   PubMed Web of Science ®Google Scholar
• Sarangapani , R. , Teeguarden , J. , Plotzke , K. P. , McKim , J. M. Jr and Andersen , M. E. 2002 . Dose-response modeling of cytochrome p450 induction in rats by octamethylcyclotetrasiloxane . Toxicol. Sci. , 67 : 159 – 172 .
   PubMed Web of Science ®Google Scholar
• Schrenk , D. , Dekant , W. and Henschler , D. 1988 . Metabolism and excretion of S-conjungates derived from hexachlorobutandiene in the isolated perfused rat kidney . Mol. Pharmacol. , 34 : 407 – 412 .
   PubMed Web of Science ®Google Scholar
• Thede , B. 1987 . Study of [14C] atrazine dose/response relationship in the rat , 1 – 33 . Greensboro, NC : Ciba-Geigy Corporation .
   Google Scholar
• Timchalk , C. , Dryzga , M. D. , Langvardt , P. W. , Kastl , P. E. and Osborne , D. W. 1990 . Determination of the effect of tridiphane on the pharmacokinetics of [14C]-atrazine following oral administration to male Fisher 344 rats . Toxicology , 61 : 27 – 40 .
   PubMed Web of Science ®Google Scholar
• U.S. Environmental Protection Agency. 2001. Revised preliminary human health risk assessment on atrazine. Registration Branch 3, Health Effects Division, Office of Pesticide Programs.
   Google Scholar
• Gargas , M. L. , Andersen , M. E. , Teo , S. K. , Batra , R. , Fennell , T. R. and Kedderis , G. L. 1995 . A physiologically based dosimetry description of acrylonitrile and cyanoethylene oxide in the rat . Toxicol. Appl. Pharmacol. , 134 : 185 – 194 .
   PubMed Web of Science ®Google Scholar
• Hays , S. M. , Elswick , W. A. , Blumenthal , G. M. , Welsch , F. , Conolly , R. B. and Gargas , M. L. 2000 . Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats . Toxicol. Appl. Pharmacol. , 163 : 67 – 74 .
   PubMed Web of Science ®Google Scholar
• Rappaport , S. M. and Yeowell-O'Connel , K. 1999 . Protein adducts as dosimeters of human exposure to styrene, styrene-7,8-oxide, and benzene . Toxicol. Lett. , 108 : 117 – 126 .
   PubMed Web of Science ®Google Scholar
• Kramer , E. and Routh , J. I. 1973 . The binding of salicylic acid and acetylsalicylic acid to human serum albumin . Clin. Biochem. , 6 : 98 – 105 .
   PubMed Web of Science ®Google Scholar
• Newton , J. F. , Hoefle , D. , Gemborys , M. W. , Mudge , G. H. and Hook , J. B. 1986 . Metabolism and excretion of a glutathione conjugate of acetaminophen in the isolated perfused rat kidney . J. Pharmacol. Exp. Ther. , 237 : 519 – 524 .
   PubMed Web of Science ®Google Scholar
• Nguyen , H. T. 1999 . “ Transport Proteins ” . In The clinical chemistry of laboratory animals , Edited by: Leob , W. F. and Quimby , F. W. 309 – 311 . Philidelphia : Taylor & Francis .
   Google Scholar
• Phillips , D. H. and Farmer , P. B. 1994 . Evidence for DNA and protein binding by strene and styrene oxide . Crit. Rev. Toxicol. , 24 : S35 – S46 .
   PubMed Web of Science ®Google Scholar
• Ramsey , J. C. and Andersen , M. E. 1984 . A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans . Toxicol. Appl. Pharmacol. , 73 : 159 – 175 .
   PubMed Web of Science ®Google Scholar
• Rappaport , S. M. , Ting , D. , Jin , Z. , Yeowell-O'Connell , K. , Waidyanatha , S. and McDonald , T. 1993 . Application of Raney nickel to measure adducts of styrene oxide with hemoglobin and albumin . Chem. Res. Toxicol. , 6 : 238 – 244 .
   PubMed Web of Science ®Google Scholar